BRAF and neoplasm: Thus, to experimentally validate this metabolic gene signature, we compared a BRAFV600E-mutated papillary (BCPAP) tumour cell line and the BRAF wild-type normaloid thyroid follicular epithelial cell line (Nthy-ori 3-1).